Skip to content

Carbohydrate Antigen 19-9 Assay kit(Chemiluminescence Immunoassay Method）

by Shenzhen Dake Medical Technology Co., Ltd China EUDAMED

Ref 25 testsModel 25 tests，50 tests，2×50 tests，100 tests，2×100 tests

EMDN W0102030103

Regulatory status

as of 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDR Number697846523ProteinC06RP Basic UDI-DIDate22 May 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Not covered

European Union — CE/IVDR Active

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 22 Oct 2026

Model / Reference
25 tests，50 tests，2×50 tests，100 tests，2×100 tests, 25 tests
Primary DI / UDI-DI
06978465237306
Basic UDI-DI
697846523ProteinC06RP
EMDN Code
W0102030103 Cancer antigen 19-9
Device Class
Class C
Market of Registration
Austria

Manufacturer details

EUDAMED SRN
CN-MF-000047336
Authorised representative
HyperCert Limited B.V. NL-AR-000047746

Other devices from Shenzhen Dake Medical Technology Co., Ltd

See all devices from Shenzhen Dake Medical Technology Co., Ltd →

Properties & raw data

Show properties, registry sources and raw records
  • Animal Tissues
  • Reagent
  • Professional Testing
Other properties (8)
  • Sterile: No
  • Human Tissues: No
  • Microbial Substances: No
  • Self Testing: No
  • Near-Patient Testing: No
  • Companion Diagnostics: No
  • Surgical Instrument: No
  • New Device: No

Sources (1)

  • EUDAMED 5c14fac1-ae8c-4ae9-b287-1d7afdceeeda 61 fields · synced 22 Oct 2026